Clinical efficacy of long-term treatment in patients with vascular dementia

To study efficacy and safety of prolonged course of cerebrolysin therapy in vascular dementia, 48 patients, aged from 59—77 years, with mild and moderate dementia have been studied. A potential of 3-years course of cerebrolysin therapy to slow down the progression of cognitive impairment in patients...

Full description

Saved in:
Bibliographic Details
Main Author: I. A. Suvorova
Format: Article
Language:English
Published: Siberian State Medical University (Tomsk) 2011-04-01
Series:Бюллетень сибирской медицины
Subjects:
Online Access:https://bulletin.ssmu.ru/jour/article/view/1367
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849772190991384576
author I. A. Suvorova
author_facet I. A. Suvorova
author_sort I. A. Suvorova
collection DOAJ
description To study efficacy and safety of prolonged course of cerebrolysin therapy in vascular dementia, 48 patients, aged from 59—77 years, with mild and moderate dementia have been studied. A potential of 3-years course of cerebrolysin therapy to slow down the progression of cognitive impairment in patients with vascular dementia has been studied in the open study. Efficacy and safety of cerebrolysin were assessed clinically and with a battery of widespread scales and neuropsychological tests. The improvement of cognitive, functional and motor activities in patients with mild and moderate dementia indicate the high effectiveness of cerebrolysin. A prolonged therapy allows to prevent the progression of cognitive impairment and development of vascular dementia.
format Article
id doaj-art-c206dc5be8e14c6cae90c8f424d55b63
institution DOAJ
issn 1682-0363
1819-3684
language English
publishDate 2011-04-01
publisher Siberian State Medical University (Tomsk)
record_format Article
series Бюллетень сибирской медицины
spelling doaj-art-c206dc5be8e14c6cae90c8f424d55b632025-08-20T03:02:23ZengSiberian State Medical University (Tomsk)Бюллетень сибирской медицины1682-03631819-36842011-04-01102929710.20538/1682-0363-2011-2-92-97881Clinical efficacy of long-term treatment in patients with vascular dementiaI. A. Suvorova0Иркутский государственный институт усовершенствования врачейTo study efficacy and safety of prolonged course of cerebrolysin therapy in vascular dementia, 48 patients, aged from 59—77 years, with mild and moderate dementia have been studied. A potential of 3-years course of cerebrolysin therapy to slow down the progression of cognitive impairment in patients with vascular dementia has been studied in the open study. Efficacy and safety of cerebrolysin were assessed clinically and with a battery of widespread scales and neuropsychological tests. The improvement of cognitive, functional and motor activities in patients with mild and moderate dementia indicate the high effectiveness of cerebrolysin. A prolonged therapy allows to prevent the progression of cognitive impairment and development of vascular dementia.https://bulletin.ssmu.ru/jour/article/view/1367vascular dementiacognitive impairmentcerebrolysin
spellingShingle I. A. Suvorova
Clinical efficacy of long-term treatment in patients with vascular dementia
Бюллетень сибирской медицины
vascular dementia
cognitive impairment
cerebrolysin
title Clinical efficacy of long-term treatment in patients with vascular dementia
title_full Clinical efficacy of long-term treatment in patients with vascular dementia
title_fullStr Clinical efficacy of long-term treatment in patients with vascular dementia
title_full_unstemmed Clinical efficacy of long-term treatment in patients with vascular dementia
title_short Clinical efficacy of long-term treatment in patients with vascular dementia
title_sort clinical efficacy of long term treatment in patients with vascular dementia
topic vascular dementia
cognitive impairment
cerebrolysin
url https://bulletin.ssmu.ru/jour/article/view/1367
work_keys_str_mv AT iasuvorova clinicalefficacyoflongtermtreatmentinpatientswithvasculardementia